University researchers have conducted the first small-scale human trial with Akkermansia muciniphila  Thirty-two overweight or obese volunteers were divided into 3 groups and received daily oral doses of live Akkermansia muciniphila, pasteurized inactivated bacteria, and a placebo, without changing diet and exercise habits  The results showed that volunteers who took the killed bacteria after 3 months had improved insulin sensitivity and decreased plasma total cholesterol levels
The above indicators continued to deteriorate in the volunteers who took the placebo
Taking the inactivated bacteria can improve the metabolism of the human body